These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 15553071

  • 1. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W, Pawłowska M.
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
    Jevtović Dj, Ranin J, Salemović D, Pesić I, Dragović G, Zerjav S, Djurković-Djaković O.
    Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad, ICoNA Study Group.
    AIDS; 2007 Mar 12; 21(5):599-606. PubMed ID: 17314522
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Grade 3-4 liver enzyme elevation during HAART in HIV and hepatitis C co-infected adults.
    Yunihastuti E, Gani RA, Lesmana LA, Sundaru H, Djauzi S.
    Acta Med Indones; 2009 Jul 12; 41(3):130-5. PubMed ID: 19752485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J, Melguizo I, Fernández-Rivera FJ, García-García A, Mira JA, Ramos AJ, Rivera JM, Pineda JA.
    Eur J Clin Microbiol Infect Dis; 2002 Nov 12; 21(11):775-81. PubMed ID: 12461586
    [Abstract] [Full Text] [Related]

  • 12. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J, Mira JA, López-Cortés LF, Santos I, Girón-González JA, González-Serrano M, Merino D, Hernández-Quero J, Rivero A, Merchante N, Trastoy M, Carrillo-Gómez R, Arizcorreta-Yarza A, Gómez-Mateos J, Pineda JA.
    Antivir Ther; 2006 Nov 12; 11(7):839-46. PubMed ID: 17302246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [HIV and HCV infections--clinical implications].
    Pawłowska M, Halota W, Grabczewska E.
    Przegl Epidemiol; 2004 Nov 12; 58 Suppl 1():71-5. PubMed ID: 15807161
    [Abstract] [Full Text] [Related]

  • 15. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups.
    Weissbrich B, Langmann P, Schubert J, Jassoy C, Klinker H.
    Eur J Med Res; 2003 Nov 12; 8(11):495-8. PubMed ID: 14644704
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
    Cooper CL, Mills E, Angel JB.
    AIDS; 2007 Jan 02; 21(1):71-6. PubMed ID: 17148970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL.
    Clin Infect Dis; 2005 Jul 01; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [Abstract] [Full Text] [Related]

  • 20. Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy.
    Tuma P, Medrano J, Resino S, Vispo E, Madejón A, Sánchez-Piedra C, Rivas P, Labarga P, Martín-Carbonero L, Barreiro P, Soriano V.
    Antivir Ther; 2010 Jul 01; 15(6):881-6. PubMed ID: 20834100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.